Atlas Trials

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis

Clinical trial NCT06498089 · RECRUITING

Trial details

NCT number
NCT06498089
Sponsor
Shanghai Zhongshan Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Takayasu Arteritis
Start date
2024-06-28
Primary completion
2026-06-30
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.